Perrigo explores sale of royalties of drug Tysabri: sources

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Perrigo explores sale of royalties of drug Tysabri: sources
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 222.67 +6.63 (3.07%)
Previous Close $216.04    52 Week High $333.65 
Open $218.20    52 Week Low $223.02 
Day High $225.59    P/E 28.51 
Day Low $216.97    EPS $7.81 
Volume 1,268,134       

Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

Perrigo (NYSE: PRGO) Delayed: 14.49 +0.06 (0.42%)
Previous Close $14.43    52 Week High $156.03 
Open $14.45    52 Week Low $79.72 
Day High $14.85    P/E N/A 
Day Low $14.30    EPS $0.00 
Volume 2,687,015